Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Case report
Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,870 | Dovepress* | 4,441+ | 755 | 5,196 | |
| PubMed Central* | 429 | 125 | 554 | ||
| Totals | 4,870 | 880 | 5,750 | ||
| *Since 29 May 2019 | |||||
View citations on PubMed Central and Google Scholar